CEREBROSPINAL-FLUID (CSF) POLYAMINES AND CARCINOEMBRYONIC ANTIGEN (CEA) IN MENINGEAL CARCINOMATOSIS

被引:0
|
作者
YAP, BS [1 ]
YAP, HY [1 ]
NISHIOKA, K [1 ]
BODEY, GP [1 ]
机构
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,HOUSTON,TX 77030
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:187 / 187
页数:1
相关论文
共 50 条
  • [41] GOLDFISH EPENDYMINS - CEREBROSPINAL-FLUID PROTEINS OF MENINGEAL ORIGIN
    HOFFMANN, W
    PROGRESS IN BRAIN RESEARCH, 1992, 91 : 13 - 17
  • [42] MENINGEAL HEMORRHAGE IN INFANTS AND LOW SUGAR IN CEREBROSPINAL-FLUID
    DIEBLER, C
    AICARDI, J
    ARCHIVES FRANCAISES DE PEDIATRIE, 1973, 30 (10): : 1031 - 1035
  • [43] THE INFLUENCE OF CEREBROSPINAL-FLUID CIRCULATION ON THE DEVELOPMENT OF THE MENINGEAL TISSUE
    KRAHN, V
    ACTA ANATOMICA, 1987, 130 (01): : 50 - 50
  • [44] ASSAY PROCEDURES FOR POLYAMINES IN URINE, SERUM, AND CEREBROSPINAL-FLUID
    SEILER, N
    CLINICAL CHEMISTRY, 1977, 23 (09) : 1519 - 1526
  • [45] HUMAN CEREBROSPINAL-FLUID (CSF) PHARMACOKINETICS OF CEFTIZOXIME
    CABLE, DC
    EDRALIN, G
    OVERTURF, G
    CLINICAL RESEARCH, 1982, 30 (01): : A128 - A128
  • [46] REGIONAL SPINAL CEREBROSPINAL-FLUID (CSF) VOLUMES
    FINK, BR
    MARAVILLA, KR
    RICHARDS, TL
    SLOAN, R
    ANESTHESIOLOGY, 1994, 81 (3A) : A231 - A231
  • [47] AUTONOMIC INFLUENCES ON PRODUCTION OF CEREBROSPINAL-FLUID (CSF)
    HAYWOOD, JR
    VOGH, BP
    PHARMACOLOGIST, 1976, 18 (02): : 135 - 135
  • [48] ANALYSIS OF CEREBROSPINAL-FLUID (CSF) WITH CHROMOGENIC ASSAYS
    CULLMANN, W
    DICK, W
    MULLER, N
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 1983, 51 (07) : 255 - 258
  • [49] CLINICAL PHARMACOKINETICS OF ACETAMINOPHEN IN THE CEREBROSPINAL-FLUID (CSF)
    BANNWARTH, B
    NETTER, P
    LAPICQUE, F
    GILLET, P
    PERE, P
    BOCCARD, E
    ROYER, RJ
    GAUCHER, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (02) : 134 - 134
  • [50] AMINES AND THEIR METABOLITES IN CEREBROSPINAL-FLUID (CSF) IN DEPRESSION
    GJERRIS, A
    CHRISTENSEN, NJ
    LINNOILA, M
    RAFAELSEN, OJ
    CLINICAL NEUROPHARMACOLOGY, 1986, 9 : 72 - 73